[HTML][HTML] Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European …

…, JH Dalle, F Dignan, T Fukuda, A Huynh… - Bone marrow …, 2016 - nature.com
Sinusoidal obstruction syndrome, also known as veno-occlusive disease (SOS/VOD), is a
potentially life threatening complication that can develop after hematopoietic cell …

[PDF][PDF] Front-line transplantation program with lenalidomide, bortezomib, and dexamethasone combination as induction and consolidation followed by lenalidomide …

…, AM Stoppa, C Gentil, S Wuilleme, A Huynh… - J Clin …, 2014 - researchgate.net
Purpose The three-drug combination of lenalidomide, bortezomib, and dexamethasone (RVD)
has shown significant efficacy in multiple myeloma (MM). The Intergroupe Francophone …

[HTML][HTML] Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and …

…, JH Dalle, RF Duarte, T Fukuda, A Huynh… - Bone marrow …, 2015 - nature.com
Sinusoidal obstruction syndrome or veno-occlusive disease (SOS/VOD) is a potentially life-threatening
complication of hematopoietic SCT (HSCT). This review aims to highlight, on …

Bone marrow mesenchymal stem cells are abnormal in multiple myeloma

J Corre, K Mahtouk, M Attal, M Gadelorge, A Huynh… - Leukemia, 2007 - nature.com
Recent literature suggested that cells of the microenvironment of tumors could be abnormal
as well. To address this hypothesis in multiple myeloma (MM), we studied bone marrow …

Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia

N Dhédin, A Huynh, S Maury, R Tabrizi… - Blood, The Journal …, 2015 - ashpublications.org
Because a pediatric-inspired Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)
protocol yielded a markedly improved outcome in adults with Philadelphia …

Prognostic factors for survival and response after high‐dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients

…, P Bourquelot, T Facon, A Huynh… - British journal of …, 1998 - Wiley Online Library
We retrospectively investigated the feasibility and the toxicity of autologous stem cell
transpantation (ASCT) in 21 cases of systemic amyloidosis (AL). The conditioning regimens …

Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study …

M Roussel, P Moreau, A Huynh, JY Mary… - Blood, The Journal …, 2010 - ashpublications.org
Autologous stem cell transplantation (ASCT) is recommended for younger patients with
newly diagnosed multiple myeloma. Achieving complete response (CR) or at least very good …

Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study b the Société Française de Greffe de Moelle et de Thérapie …

…, J El Cheikh, CE Bulabois, A Huynh… - Journal of clinical …, 2012 - orbi.uliege.be
Purpose : To investigate the impact of prior-to-transplantation azacitidine (AZA) on patient
outcome after allogeneic stem-cell transplantation (alloSCT) for myelodysplastic syndrome (…

Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial [see …

M Attal, F Huguet, H Rubie, A Huynh, JP Charlet… - 1992 - ashpublications.org
Hepatic veno-occlusive disease (VOD) is a major regimen-related toxicity after bone marrow
transplantation (BMT). Endothelial injury, leading to deposition of coagulation factors within …

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study

…, E Tavernie-Tardy, M Attal, A Huynh… - Journal of …, 2010 - academic.oup.com
Objectives Cytomegalovirus (CMV) drug resistance is a therapeutic challenge in the transplant
setting. No longitudinal cohort studies of CMV resistance in a real-life setting have been …